Ruta Rao, MD | Authors


700 W 800 N STE 200


HER2-Directed Treatment of Metastatic Breast Cancer: Unanswered Questions

March 15, 2013

As more drugs become available in the HER2 arena, clinicians will be faced with increasing challenges regarding which sequences and combinations of drugs will be the best for their patients. In the era in which we practice, a great deal of this is likely to be dictated by the payers.